Harry A. Waisman

3.9k total citations
109 papers, 2.4k citations indexed

About

Harry A. Waisman is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Harry A. Waisman has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Clinical Biochemistry, 38 papers in Physiology and 34 papers in Molecular Biology. Recurrent topics in Harry A. Waisman's work include Metabolism and Genetic Disorders (55 papers), Diet and metabolism studies (23 papers) and Amino Acid Enzymes and Metabolism (17 papers). Harry A. Waisman is often cited by papers focused on Metabolism and Genetic Disorders (55 papers), Diet and metabolism studies (23 papers) and Amino Acid Enzymes and Metabolism (17 papers). Harry A. Waisman collaborates with scholars based in United States and Australia. Harry A. Waisman's co-authors include Theo Gerritsen, James G. Vaughn, Régis Daniel, Harry F. Harlow, George R. Kerr, V H Auerbach, R.A. Freedland, Charles Heidelberger, Anthony R. Curreri and Forde A. McIver and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Harry A. Waisman

108 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry A. Waisman United States 28 853 764 443 421 366 109 2.4k
Helen K. Berry United States 27 958 1.1× 635 0.8× 591 1.3× 267 0.6× 171 0.5× 110 1.9k
J. N. Cumings United Kingdom 30 374 0.4× 1.0k 1.3× 640 1.4× 150 0.4× 243 0.7× 89 2.7k
W. Thompson United Kingdom 32 318 0.4× 1.2k 1.6× 334 0.8× 89 0.2× 484 1.3× 80 3.5k
Sídney M. Gospe United States 30 969 1.1× 896 1.2× 239 0.5× 311 0.7× 337 0.9× 96 2.8k
Pinar T. Ozand Saudi Arabia 34 1.9k 2.2× 2.2k 2.9× 923 2.1× 375 0.9× 383 1.0× 163 4.4k
Κ. Hyland United States 30 995 1.2× 789 1.0× 289 0.7× 581 1.4× 486 1.3× 69 2.5k
H.R. Scholte Netherlands 35 1.8k 2.1× 2.6k 3.5× 602 1.4× 132 0.3× 209 0.6× 100 3.7k
Stefan Silbernagl Germany 33 345 0.4× 1.2k 1.6× 315 0.7× 53 0.1× 534 1.5× 108 2.7k
Roy A. Gravel Canada 32 741 0.9× 1.8k 2.3× 535 1.2× 1.4k 3.3× 95 0.3× 69 3.4k
M. Estela Rubio‐Gozalbo Netherlands 33 1.6k 1.9× 1.2k 1.6× 806 1.8× 454 1.1× 478 1.3× 114 2.8k

Countries citing papers authored by Harry A. Waisman

Since Specialization
Citations

This map shows the geographic impact of Harry A. Waisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry A. Waisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry A. Waisman more than expected).

Fields of papers citing papers by Harry A. Waisman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry A. Waisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry A. Waisman. The network helps show where Harry A. Waisman may publish in the future.

Co-authorship network of co-authors of Harry A. Waisman

This figure shows the co-authorship network connecting the top 25 collaborators of Harry A. Waisman. A scholar is included among the top collaborators of Harry A. Waisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry A. Waisman. Harry A. Waisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waisman, Harry A., et al.. (1973). Effects of oral contraceptives and obesity on carrier tests for phenylketonuria. Clinica Chimica Acta. 44(2). 183–192. 11 indexed citations
2.
Fischer, Milton H., et al.. (1972). Generalized growth retardation in rats induced by prenatal exposure to methylazoxymethyl acetate. Teratology. 5(2). 223–232. 59 indexed citations
3.
Lines, D. R. & Harry A. Waisman. (1971). Urinary amino acid excretion in phenylketonuric, hyperphenylalaninemic, and normal patients. The Journal of Pediatrics. 78(3). 474–480. 10 indexed citations
4.
Waisman, Harry A. & George R. Kerr. (1970). Fetal growth and development. McGraw-Hill eBooks. 2 indexed citations
5.
Geison, R.L. & Harry A. Waisman. (1970). Plasma and Tissue Cholesterol and Lipid Levels in Rabbits on L-Histidine-Supplemented Diets. Experimental Biology and Medicine. 133(1). 234–237. 15 indexed citations
6.
Waisman, Harry A., et al.. (1967). Low-Phenylalanine Diets for Pregnant PKU Heterozygotes Are Unnecessary. PEDIATRICS. 40(6). 1062–1063. 1 indexed citations
7.
Waisman, Harry A.. (1966). Some Newer Inborn Errors of Metabolism. Pediatric Clinics of North America. 13(2). 469–501. 7 indexed citations
8.
Harlow, Harry F. & Harry A. Waisman. (1965). Response : Experimental Phenylketonuria. Science. 148(3670). 579–579. 2 indexed citations
9.
Waisman, Harry A., et al.. (1964). Homocystinuria: Absence of Cystathionine in the Brain. Science. 145(3632). 588–588. 55 indexed citations
10.
Freedland, R.A., et al.. (1964). Influence of amino acids on rat liver phenylalanine hydroxylase activity. American Journal of Physiology-Legacy Content. 206(2). 341–344. 15 indexed citations
11.
Ptáček, Louis J., John M. Opitz, David W. Smith, Theo Gerritsen, & Harry A. Waisman. (1963). The Cornelia de Lange syndrome. The Journal of Pediatrics. 63(5). 1000–1020. 135 indexed citations
12.
Gerritsen, Theo, et al.. (1963). Urinary excretion of 3,4-dihydroxyphenylalanine (DOPA) in two children of short stature with malnutrition. The Journal of Pediatrics. 62(2). 208–216. 8 indexed citations
13.
Waisman, Harry A., et al.. (1962). Effect of dietary phenylalanine and tryptophan on brain serotonin. Archives of Biochemistry and Biophysics. 97(1). 181–184. 34 indexed citations
14.
Freedland, R.A., et al.. (1961). The effect of aromatic amino acids on the hydroxylation of tryptophan. Biochemical and Biophysical Research Communications. 6(3). 227–231. 21 indexed citations
15.
Wang, Hwa L., Newton E. Morton, & Harry A. Waisman. (1961). Increased reliability for the determination of the carrier state in phenylketonuria.. PubMed. 13. 255–61. 20 indexed citations
16.
Auerbach, Victor H., Ronald A. Pieringer, & Harry A. Waisman. (1959). The effect of 3-amino-1,2,4-triazole on the synthesis of tryptophan peroxidase-oxidase. Archives of Biochemistry and Biophysics. 82(2). 370–379. 13 indexed citations
17.
Lowe, C. U., Clifford A. Smith, Francis Scott Smyth, et al.. (1958). On the feeding of solid foods to infants.. PEDIATRICS. 21. 685–692. 32 indexed citations
18.
Waisman, Harry A., et al.. (1957). Nucleic acid precursors and nucleotides in normal and leukemic blood. I. comparison of formic acid chromatograms.. PubMed. 17(10). 942–7. 5 indexed citations
19.
Poncher, Henry G., et al.. (1952). Treatment of acute leukemia in children with and without folic acid antagonists. The Journal of Pediatrics. 41(4). 377–394. 14 indexed citations
20.
Segar, William E., et al.. (1951). Renal Clearance of Endogenous Phosphate in Infants and Children. Experimental Biology and Medicine. 77(1). 83–87. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026